2013

  • Remedica’s new oncology facility begun operations. Imarem® (Imatinib), an anti-neoplastic agent, was registered in Cyprus
  • Successful inspection by the Brazilian Authorities (ANVISA)
  • The company has been included by the IN BUSINESS Magazine in its list of the fifty most socially responsible companies in Cyprus
  • Remedica announced the Pattihis Family Scholarship for the MSc Management Degree in the Department of Management Science and Innovation at University College London (UCL), UK
  • Remedica sponsored the Cyprus University of Technology “Open Access Author Fund” so that it’s library can offer open access to students to publish their research.
Go Back